Divyaswathi Citla Sridhar, MD MS/LinkedIn
Nov 20, 2025, 13:56
Glanzmann Thrombasthenia Is More Common Than Previously Thought
Divyaswathi Citla Sridhar, Pediatric Hematologist and Oncologist at Arkansas Children’s Hospital, shared a post on LinkedIn:
”Our analysis of 1,059 U.S. patients with Glanzmann Thrombasthenia (GT) shows that GT prevalence may be significantly higher in the United States than previously recognized, and underscores the substantial clinical burden from recurrent bleeding, anemia, and transfusion dependence.
Huge shout-out to my fantastic collaborator, Daniel Liu, for his expertise in working with this complex dataset.”
Read the full article here.
Title: Characterising Glanzmann Thrombasthenia in the United States: Real-World Data From the EPIC Cosmos Dataset
Authors: Divyaswathi Citla-Sridhar, Daniel Liu

Stay updated with Hemostasis today.
Arkansas Children’s Hospital
bleeding disorders
Daniel Liu
Divyaswathi Citla-Sridhar
EPIC Cosmos Dataset
Glanzmann thrombasthenia
Glanzmann Thrombasthenia Support Group
Glanzmann's Research Foundation
haemophilia
Health
Hematology
Hemostasis
Hemostasis Today
Inherited Bleeding Disorder
Medicine
thrombosis
-
Dec 16, 2025, 16:50Raul Santos on Sex-Specific Biology and Plasma Fructose Levels in Cardiovascular Risk
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
